Terms: = Uterine cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
2923 results:
1. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
[TBL] [Abstract] [Full Text] [Related]
2. Knowledge of cytology results affects the performance of colposcopy: a crossover study.
Lalande E; Clarke H; Undurraga M; Nguyen VQH; Jaksic C; Goffin F; Arbyn M; Jeronimo J; Tille JC; Saiji E; Vassilakos P; Petignat P
BMC Womens Health; 2024 Mar; 24(1):189. PubMed ID: 38515088
[TBL] [Abstract] [Full Text] [Related]
3. Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
Santoro A; Bragantini E; Castiglione F; Ganesan R; Matias-Guiu X; Frattini M; Gallotta V; Garcia P; Pattni Y; Tsiampali-Laprell J; Bisaro B; Barbareschi M; Zannoni GF;
Pathologica; 2024 Feb; 116(1):32-45. PubMed ID: 38482673
[TBL] [Abstract] [Full Text] [Related]
4. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
[TBL] [Abstract] [Full Text] [Related]
5. Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
Khushman MM; Toboni MD; Xiu J; Manne U; Farrell A; Lou E; Shields AF; Philip PA; Salem ME; Abraham J; Spetzler D; Marshall J; Jayachandran P; Hall MJ; Lenz HJ; Sahin IH; Seeber A; Powell MA
Clin Cancer Res; 2024 May; 30(9):1906-1915. PubMed ID: 38350001
[TBL] [Abstract] [Full Text] [Related]
6. Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes.
Yoshida H; Matsuo K; Machida H; Matsuzaki S; Maeda M; Terai Y; Fujii T; Mandai M; Kawana K; Kobayashi H; Mikami M; Nagase S
Int J Gynecol Cancer; 2024 Apr; 34(4):510-518. PubMed ID: 38316444
[TBL] [Abstract] [Full Text] [Related]
7. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
[TBL] [Abstract] [Full Text] [Related]
8. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract] [Full Text] [Related]
9. Next-generation sequencing and immunohistochemistry approaches for microsatellite instability detection in endometrial cancer.
Ali AS; Alalem LS
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):237-242. PubMed ID: 38279425
[TBL] [Abstract] [Full Text] [Related]
10. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
[TBL] [Abstract] [Full Text] [Related]
11. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
[TBL] [Abstract] [Full Text] [Related]
12. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
[TBL] [Abstract] [Full Text] [Related]
13. New Insights into Lynch Syndrome: A Narrative Review.
Ene CV; Bulai CTLA; Geavlete P; Popescu RI; Vacaroiu IA; Georgescu DE; Isaconi IV; Munteanu MDLA; Ene CD; Militaru A; Geavlete B; Multescu R
Chirurgia (Bucur); 2023 Dec; 118(6):584-595. PubMed ID: 38228591
[TBL] [Abstract] [Full Text] [Related]
14. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
[TBL] [Abstract] [Full Text] [Related]
15. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Kaya M; Post CCB; Tops CM; Nielsen M; Crosbie EJ; Leary A; Mileshkin LR; Han K; Bessette P; de Boer SM; Jürgenliemk-Schulz IM; Lutgens L; Jobsen JJ; Haverkort MAD; Nout RA; Kroep J; Creutzberg CL; Smit VTHBM; Horeweg N; van Wezel T; Bosse T
Mod Pathol; 2024 Mar; 37(3):100423. PubMed ID: 38191122
[TBL] [Abstract] [Full Text] [Related]
16. Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases.
Miyama Y; Kato T; Sato M; Yabuno A; Hasegawa K; Yasuda M
Diagn Pathol; 2024 Jan; 19(1):6. PubMed ID: 38178127
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic and reproductive outcomes in women who had uterine myomas removed during cesarean section and sutured using different techniques.
Dai QH; Zhang L; Chen AE
BMC Womens Health; 2024 Jan; 24(1):7. PubMed ID: 38166995
[TBL] [Abstract] [Full Text] [Related]
18. Effect of
Santos KVGD; da Silva RLM; Sarmento ACA; Medeiros KS; Pessoa RL; Dantas DV; Dantas RAN
Integr Cancer Ther; 2023; 22():15347354231220608. PubMed ID: 38140826
[TBL] [Abstract] [Full Text] [Related]
19. The minimum effective dose (ED
Tyagi A; Nigam C; Malhotra RK; Bodh P; Deep S; Singla A
Int J Obstet Anesth; 2024 Feb; 57():103962. PubMed ID: 38103940
[TBL] [Abstract] [Full Text] [Related]
20. Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types.
Song WM; Elmas A; Farias R; Xu P; Zhou X; Hopkins B; Huang KL; Zhang B
J Hematol Oncol; 2023 Dec; 16(1):120. PubMed ID: 38102665
[TBL] [Abstract] [Full Text] [Related]
[Next]
